Genome-wide identification of CRISPR/Cas9 off-targets in human genome.
about
CRISPR-Cas9 Genome Editing in DrosophilaCRISPR-Cas9: A Revolutionary Tool for Cancer ModellingOff-target Effects in CRISPR/Cas9-mediated Genome EngineeringSynthetic RNAs for Gene Regulation: Design Principles and Computational ToolsThe application of genome editing in studying hearing lossCas9-chromatin binding information enables more accurate CRISPR off-target prediction.Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing.A CRISPR view of development.Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNAGenome-Scale CRISPR-Mediated Control of Gene Repression and ActivationGUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.Applications of CRISPR-Cas9 mediated genome engineering.A genome-wide analysis of Cas9 binding specificity using ChIP-seq and targeted sequence capture.Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activatorsStructure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavageHigh-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding.Editing the epigenome: technologies for programmable transcription and epigenetic modulation.Deciphering relationship between microhomology and in-frame mutation occurrence in human CRISPR-based gene knockoutReal-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9.Progress in Genome Editing Technology and Its Application in Plants.Proteomics in the genome engineering era.CRISPR-Cas9 for medical genetic screens: applications and future perspectives.CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.CRISPR-Cas9 technology: applications and human disease modelling.Applications of the CRISPR/Cas9 system in murine cancer modeling.Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection.CRISPR/Cas9-mediated noncoding RNA editing in human cancers.Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells.Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation In Vivo in the Escherichia coli Type I-E CRISPR-Cas System.Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins.Comparison and optimization of CRISPR/dCas9/gRNA genome-labeling systems for live cell imaging.Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.CRISPR/Cas9-Mediated Multiplex Genome Editing of the and Genes in LCRISPR/Cas9-mediated mutagenesis of homologous genes in Chinese kale
P2860
Q26314632-D66525EA-803A-4DA7-824A-15BB6F40ECC2Q26782773-465DA9F7-554A-4A9D-BD92-45921AB679DDQ26859390-3FF256CA-D81E-4C00-AE69-43E0128C44F4Q27694764-B1960CED-12E3-47A1-92C8-3F9D524FBE7CQ28081706-C0D578BD-826B-4EA5-8F8E-E30F27661233Q30279249-24617F60-CB9B-4E16-A0A2-471638D94C8DQ34044207-ADE3B122-1919-4CE8-A916-9FF40F605603Q34342877-C76BB353-8746-4094-A4DB-79AFAC96CBFDQ34433586-31C1AB4F-C803-4E86-A6EA-AD57ECCF6659Q34443093-EE9625AD-8891-4AB4-8345-EA30D81A8DAAQ34454104-2C9A4792-6AFE-4964-99AF-7E04AA001B49Q34669857-BDEFF7F3-664C-41DA-A715-DBDE6CF42043Q35237040-C304CEBA-8D63-4505-864E-3E490470DEA2Q35876055-DDD2FBF4-D411-4FC3-BD7D-891DC3DD5962Q36160691-BDB349A6-1BFD-46C5-83A8-6055710B9738Q36369721-77D60D2E-D88C-4ECA-81C8-F6484B0C2334Q37042113-1C6303C1-2C08-4D60-86A2-0BCC9C072CDEQ37254634-D4DFF020-EE7C-465C-ACD3-862BFC3734C9Q37263726-53BD015F-7ADB-4D6C-9D8A-3FCB6E74E19DQ37639765-1E351641-28A2-4F3F-B4A9-2408B98A74C7Q38618624-F5E4575F-F267-45FD-BBB2-8EAD2AC3BBEDQ38670939-2142B810-9F49-4A88-9092-4A0FCDE2213BQ38825322-89021014-9858-4539-941A-748A7853525CQ38848400-E9B7D022-C670-4812-9999-F97B8E53435EQ38858314-DD3374C6-71B6-4CBF-A1DC-8B90C5C6480EQ40042102-1C117779-C7DE-476C-8F5C-2ACFA985BCB2Q48189506-149DBEC8-4AB6-4FEA-8EC4-054EEECB7158Q50281015-547CFC6C-F1EC-402C-80D9-7824BC6810F0Q52318667-601A1125-4E62-4DFA-AB64-112107DCF971Q52430895-34F2E6C2-0B44-4600-B38A-B9AE58977F49Q52430952-84B3C0FC-2896-4CD6-804A-68239F8889E4Q52431433-7193C0A0-16D1-4C42-AEB5-01A444094E9EQ58749728-8D64A0EE-694D-4390-93AE-875DD3E95BA2Q59136067-5E36AC1B-818C-456E-A628-09A3452C364F
P2860
Genome-wide identification of CRISPR/Cas9 off-targets in human genome.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Genome-wide identification of CRISPR/Cas9 off-targets in human genome.
@en
Genome-wide identification of CRISPR/Cas9 off-targets in human genome.
@nl
type
label
Genome-wide identification of CRISPR/Cas9 off-targets in human genome.
@en
Genome-wide identification of CRISPR/Cas9 off-targets in human genome.
@nl
prefLabel
Genome-wide identification of CRISPR/Cas9 off-targets in human genome.
@en
Genome-wide identification of CRISPR/Cas9 off-targets in human genome.
@nl
P2093
P2860
P356
P1433
P1476
Genome-wide identification of CRISPR/Cas9 off-targets in human genome.
@en
P2093
Guangqing Lu
Jinzhi Duan
Mingliang Lou
P2860
P2888
P304
P356
10.1038/CR.2014.87
P577
2014-07-01T00:00:00Z
P5875
P6179
1030497181